FDA Inspection 1258884 — Andrew M. Smith, M.D.
The FDA completed an inspection of Andrew M. Smith, M.D. on Jan 15, 2025 in Sandy, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 15, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sandy, UT (United States)
Additional details
Clinical Investigator (CI)